Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Author: Avi Kapoor | October 08, 2025 09:34am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Wolfe Research analyst Nigel Coe upgraded Otis Worldwide Corporation (NYSE:OTIS) from Peer Perform to Outperform and announced a $109 price target. Otis Worldwide shares closed at $90.40 on Tuesday. See how other analysts view this stock.
  • Needham analyst Mike Matson upgraded Penumbra, Inc. (NYSE:PEN) from Hold to Buy and announced a $326 price target. Penumbra shares closed at $249.04 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst David Chiaverini upgraded BOK Financial Corporation (NASDAQ:BOKF) from Hold to Buy and raised the price target from $120 to $135. BOK Financial shares closed at $114.05 on Tuesday. See how other analysts view this stock.
  • JP Morgan analyst Jessica Fye upgraded Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) from Neutral to Overweight and raised the price target from $49 to $80. Ionis Pharmaceuticals shares closed at $70.22 on Tuesday. See how other analysts view this stock.

Considering buying PEN stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Posted In: BOKF IONS OTIS PEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist